Logo
DCA

Johnson & Johnson

sp500
JNJHealthcareDrug Manufacturers - General
253,04 $US
+1.23%
Dernier cours
253,04 $US
2026-07-17
Variation 24h
+1.23%
3.07 USD
Volume
7,5 M
Titres échangés
Fiabilité des données
Forte
16243 points (65 ans)

Évolution du cours

Lancer une simulation avec cet actif

JNJ

Paramètres globaux

Données disponibles du 02/01/1962 au 17/07/2026

Analyse Fondamentale

New
CAGR (5y)
5.60%
Revenue Growth
Net Margin
28.46%
Profitability
ROE
32.87%
Return on Equity
Debt / EBITDA
1.17
Solvency
PEG Ratio
5.05
Valuation vs Growth
Rev. Growth (TTM)
9.90%
Current Trend

Historique PER (5 ans)

Historical PE
Average (21.5x)
Current: 30.5x
Focus technique
JNJ
Volatilité 30j
22.78%
Écart MA50
6.03%
Écart MA200
13.51%
Écart ATH
-5.31%
Momentum 3M
8.05%
Score de risque
N/A

Volatilité modérée. Momentum neutre.

À propos de Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Investir cet actif
Acheter via Saxo Banque
🏦Courtier régulé (AMF)
🌍Accès marchés globaux
📈Outils professionnels

Lien commercial. Investir comporte des risques.

Analyse Technique & Risque

Metrics Clés

CAGR11.53%
Volatilité22.78%
Max Drawdown-18.58%

Momentum : JNJ

Indicateur synthétique
PEURNEUTREAVIDITÉ
68
Greed

Analyse Risque

VaR (95%)-2.13%
Santé DCA
95/100

Historique récent (60 jours)

DateClôtureVolume
2026-07-17253,04 $US7 516 376
2026-07-16249,97 $US8 712 227
2026-07-15247,02 $US10 005 307
2026-07-14253,85 $US6 374 562
2026-07-13257,77 $US3 873 681
2026-07-10256,98 $US5 217 403
2026-07-09259,10 $US6 294 135
2026-07-08263,40 $US6 769 400
2026-07-07267,24 $US9 081 600
2026-07-06259,33 $US5 081 102
2026-07-02263,04 $US7 901 835
2026-07-01253,98 $US6 511 339
2026-06-30253,97 $US4 525 237
2026-06-29258,51 $US8 437 817
2026-06-26254,66 $US16 242 949
2026-06-25244,88 $US10 031 648
2026-06-24241,00 $US5 041 625
2026-06-23239,08 $US7 590 889
2026-06-22231,29 $US8 393 040
2026-06-18228,39 $US18 736 849
2026-06-17234,20 $US8 442 711
2026-06-16235,18 $US7 021 889
2026-06-15235,66 $US7 485 697
2026-06-12240,87 $US6 455 583
2026-06-11238,33 $US4 861 556
2026-06-10238,49 $US6 956 293
2026-06-09237,00 $US8 191 819
2026-06-08232,16 $US7 529 093
2026-06-05232,77 $US5 636 649
2026-06-04228,17 $US7 214 694
2026-06-03223,24 $US4 565 701
2026-06-02222,89 $US3 676 189
2026-06-01223,51 $US5 962 384
2026-05-29225,33 $US6 188 580
2026-05-28230,80 $US6 733 852
2026-05-27231,29 $US5 835 500
2026-05-26230,18 $US6 427 813
2026-05-22234,34 $US5 460 721
2026-05-21231,73 $US5 196 882
2026-05-20229,32 $US3 376 613
2026-05-19230,00 $US6 002 888
2026-05-18228,92 $US9 222 828
2026-05-15226,71 $US11 232 375
2026-05-14230,80 $US3 037 929
2026-05-13230,42 $US5 327 127
2026-05-12224,26 $US8 349 434
2026-05-11221,43 $US3 625 123
2026-05-08221,32 $US3 850 388
2026-05-07222,51 $US6 771 465
2026-05-06224,62 $US7 823 079
2026-05-05225,55 $US5 271 298
2026-05-04224,20 $US8 151 408
2026-05-01227,19 $US6 022 437
2026-04-30229,85 $US8 143 777
2026-04-29227,35 $US6 884 458
2026-04-28227,79 $US5 428 778
2026-04-27225,34 $US5 498 001
2026-04-24227,50 $US5 778 847
2026-04-23230,65 $US6 947 896
2026-04-22226,10 $US6 637 218

Derniers Dividendes

DateMontant
2026-02-24+1,30 $US
2025-11-25+1,30 $US
2025-08-26+1,30 $US
2025-05-27+1,30 $US
2025-02-18+1,24 $US
2024-11-26+1,24 $US
2024-08-27+1,24 $US
2024-05-20+1,24 $US
2024-02-16+1,19 $US
2023-11-20+1,19 $US
2023-08-25+1,19 $US
2023-05-22+1,19 $US
2023-02-17+1,13 $US
2022-11-21+1,13 $US
2022-08-22+1,13 $US
2022-05-23+1,13 $US
2022-02-18+1,06 $US
2021-11-22+1,06 $US
2021-08-23+1,06 $US
2021-05-24+1,06 $US

Actifs Relatifs